Dánia -
dán -
Lægemiddelstyrelsen (Danish Medicines Agency)
levodopa/carbidopa/entacapone "rivopharm" 100+25+200 mg filmovertrukne tabletter
rivopharm limited - carbidopa, entacapon, levodopa - filmovertrukne tabletter - 100+25+200 mg
Dánia -
dán -
Lægemiddelstyrelsen (Danish Medicines Agency)
levodopa/carbidopa/entacapone "rivopharm" 125+31,25+200 mg filmovertrukne tabletter
rivopharm limited - carbidopa, entacapon, levodopa - filmovertrukne tabletter - 125+31,25+200 mg
Dánia -
dán -
Lægemiddelstyrelsen (Danish Medicines Agency)
levodopa/carbidopa/entacapone "rivopharm" 150+37,5+200 mg filmovertrukne tabletter
rivopharm limited - carbidopa, entacapon, levodopa - filmovertrukne tabletter - 150+37,5+200 mg
Dánia -
dán -
Lægemiddelstyrelsen (Danish Medicines Agency)
levodopa/carbidopa/entacapone "rivopharm" 200+50+200 mg filmovertrukne tabletter
rivopharm limited - carbidopa, entacapon, levodopa - filmovertrukne tabletter - 200+50+200 mg
Dánia -
dán -
Lægemiddelstyrelsen (Danish Medicines Agency)
levodopa/carbidopa/entacapone "rivopharm" 75+18,75+200 mg filmovertrukne tabletter
rivopharm limited - carbidopa, entacapon, levodopa - filmovertrukne tabletter - 75+18,75+200 mg
Európai Unió -
dán -
EMA (European Medicines Agency)
cufence
univar solutions bv - trientine dihydrochlorid - hepatolentikulær degeneration - andre alimentary tract and metabolism produkter, - cufence er indiceret til behandling af wilsons sygdom hos patienter, der tåler at d-penicillamin terapi, i voksne og børn i alderen 5 år eller ældre.
Európai Unió -
dán -
EMA (European Medicines Agency)
tibsovo
les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastiske midler - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.
Dánia -
dán -
Lægemiddelstyrelsen (Danish Medicines Agency)
entecavir "teva" 1 mg filmovertrukne tabletter
teva b.v. - entecavir (monohydrat) - filmovertrukne tabletter - 1 mg
Dánia -
dán -
Lægemiddelstyrelsen (Danish Medicines Agency)
levocaren 125+31,25+200 mg filmovertrukne tabletter
2care4 aps - carbidopa, entacapon, levodopa - filmovertrukne tabletter - 125+31,25+200 mg
Dánia -
dán -
Lægemiddelstyrelsen (Danish Medicines Agency)
levocaren 150+37,5+200 mg filmovertrukne tabletter
2care4 aps - carbidopa, entacapon, levodopa - filmovertrukne tabletter - 150+37,5+200 mg